Temporarily anesthetizing the retina briefly reverts the activity of the visual system to that observed in early development and enables growth of responses to the amblyopic eye, new research shows.
Levita Magnetics has received FDA 510(k) clearance for its Magnetic Surgical System (MSS) to be used in certain pediatric surgeries, with the first U.S. surgery performed at Cleveland Clinic Children’s earlier this month.
Having been commercially available for less than 12 months, the system is now offered in over 60 US clinics.
A decade ago, at age 55, Don Lewis suffered a stroke in his sleep. When he woke up, he couldn’t move his left arm or leg. Lewis’s neighbor realized his truck hadn’t moved in two days and called 911 for a welfare check. When paramedics found him, he was paralyzed on one side.
A new study led by researchers from Murdoch University’s School of Psychology, Personalized Medicine Center, and Center for Healthy Aging, Health Futures Institute has found that heart rate variability biofeedback can significantly reduce symptoms of both PTSD and chronic pain—two conditions that frequently co-occur and are notoriously difficult to treat together.
A new study provides a powerful way to study infections in environments that closely mimic human organs.
Our body’s “blood factory” consists of specialized tissue made up of bone cells, blood vessels, nerves and other cell types. Now, researchers have succeeded for the first time in recreating this cellular complexity in the laboratory using only human cells. The novel system could reduce the need for animal experiments for many applications.
Humans can “catch” fear from robots, new research has shown. The findings—by a team of psychologists from the University of Amsterdam and the University of British Columbia—shed new light on how emotions can spread through touch, with implications for human relationships, mental health, and future technologies such as virtual reality and wearable devices.
For the first time, scientists have grown functional, brain-like tissue without using any animal-derived materials or added biological coatings. The development opens the door to more controlled and humane neurological drug testing.
Philips (NYSE: PHG)+ today announced the introduction of DeviceGuide, an AI-powered tracking solution for interventional cardiology.